0000939767-15-000091.txt : 20151014 0000939767-15-000091.hdr.sgml : 20151014 20151014170508 ACCESSION NUMBER: 0000939767-15-000091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151012 FILED AS OF DATE: 20151014 DATE AS OF CHANGE: 20151014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXELIXIS, INC. CENTRAL INDEX KEY: 0000939767 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043257395 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508377000 MAIL ADDRESS: STREET 1: 210 E. GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS INC DATE OF NAME CHANGE: 20000207 FORMER COMPANY: FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20000106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lamb Peter CENTRAL INDEX KEY: 0001387306 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30235 FILM NUMBER: 151158593 MAIL ADDRESS: STREET 1: PO BOX 511, 170 HARBOR WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94083-0511 4 1 wf-form4_144485669542135.xml FORM 4 X0306 4 2015-10-12 0 0000939767 EXELIXIS, INC. EXEL 0001387306 Lamb Peter C/O EXELIXIS, INC. 210 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, Discovery Research & CSO Common Stock 2015-10-12 4 M 0 525 5.63 A 36998 D Common Stock 2015-10-12 4 M 0 1400 5.63 A 38398 D Common Stock 2015-10-12 4 M 0 2500 5.63 A 40898 D Common Stock 2015-10-12 4 M 0 8000 5.63 A 48898 D Common Stock 2015-10-12 4 M 0 20000 5.63 A 68898 D Common Stock 2015-10-12 4 M 0 28000 5.63 A 96898 D Common Stock 2015-10-12 4 M 0 84000 5.63 A 180898 D Common Stock 2015-10-12 4 M 0 19333 5.63 A 200231 D Common Stock 2015-10-12 4 M 0 39999 5.63 A 240230 D Common Stock 2015-10-12 4 M 0 39583 5.63 A 279813 D Common Stock 2015-10-12 4 M 0 56936 5.63 A 336749 D Common Stock 2015-10-12 4 S 0 300276 5.839 D 36473 D Common Stock 2015-10-13 4 M 0 600 5.63 A 37073 D Common Stock 2015-10-13 4 S 0 600 5.80 D 36473 D Common Stock 14478 I By 401(k) Option (right to buy) 5.63 2015-10-12 4 M 0 525 0 D 2010-08-05 2015-10-17 Common Stock 525.0 242815 D Option (right to buy) 5.63 2015-10-12 4 M 0 1400 0 D 2010-08-05 2015-10-17 Common Stock 1400.0 241415 D Option (right to buy) 5.63 2015-10-12 4 M 0 2500 0 D 2010-08-05 2015-10-17 Common Stock 2500.0 238915 D Option (right to buy) 5.63 2015-10-12 4 M 0 8000 0 D 2010-08-05 2015-10-17 Common Stock 8000.0 230915 D Option (right to buy) 5.63 2015-10-12 4 M 0 20000 0 D 2010-08-05 2015-10-17 Common Stock 20000.0 210915 D Option (right to buy) 5.63 2015-10-12 4 M 0 28000 0 D 2010-08-05 2015-10-17 Common Stock 28000.0 182915 D Option (right to buy) 5.63 2015-10-12 4 M 0 84000 0 D 2010-08-05 2015-10-17 Common Stock 84000.0 98915 D Option (right to buy) 5.63 2015-10-12 4 M 0 19333 0 D 2010-08-05 2015-10-17 Common Stock 19333.0 79582 D Option (right to buy) 5.63 2015-10-12 4 M 0 39999 0 D 2010-08-05 2015-10-17 Common Stock 39999.0 39583 D Option (right to buy) 5.63 2015-10-12 4 M 0 39583 0 D 2010-08-05 2015-10-17 Common Stock 39583.0 0 D Option (right to buy) 5.63 2015-10-12 4 M 0 56936 0 D 2010-08-05 2015-10-17 Common Stock 56936.0 52149 D Option (right to buy) 5.63 2015-10-13 4 M 0 600 0 D 2010-08-05 2015-10-17 Common Stock 600.0 51549 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.80 to $6.00, inclusive. The reporting person undertakes to provide to Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Represents 14,478 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of October 13, 2015. Option granted pursuant to Issuer's 2000 Equity Incentive Plan. One hundred percent (100%) of the shares vest one year from date of grant. Option granted pursuant to Issuer's 2000 Equity Incentive Plan. Thirty-three percent (33%) of the shares vest one year from date of grant, and the remaining shares vest in 24 equal monthly installments thereafter. /s/ Jeffrey J. Hessekiel, Attorney in Fact 2015-10-13